Cellumed Co.,Ltd. (KOSDAQ:049180)
1,491.00
-109.00 (-6.81%)
At close: Feb 5, 2026
Cellumed Revenue
Cellumed had revenue of 37.29B KRW in the quarter ending September 30, 2025, with 12.05% growth. This brings the company's revenue in the last twelve months to 148.55B, up 24.16% year-over-year. In the year 2024, Cellumed had annual revenue of 129.14B with 35.15% growth.
Revenue (ttm)
148.55B
Revenue Growth
+24.16%
P/S Ratio
0.55
Revenue / Employee
1.65B
Employees
90
Market Cap
81.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 129.14B | 33.59B | 35.15% |
| Dec 31, 2023 | 95.55B | -26.53B | -21.73% |
| Dec 31, 2022 | 122.09B | 22.17B | 22.19% |
| Dec 31, 2021 | 99.92B | 26.73B | 36.52% |
| Dec 31, 2020 | 73.19B | 55.27B | 308.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Home Center Holdings Co.,Ltd | 305.10B |
| Sinsin Pharmaceutical | 110.29B |
| Yellow Balloon Tour | 107.58B |
| Nice D&B | 92.11B |
| Polaris AI Pharma | 63.94B |
| Magatouch | 43.59B |
| Lightron Fiber-Optic Devices | 30.01B |
| ASTech | 24.71B |